Our Solutions

Gain strategic, in-depth insights across your product’s lifecycle.

MMS is the trusted, data-focused clinical research organization (CRO) chosen by Sponsors across the globe for our dedication to providing comprehensive, integrated solutions in all aspects of drug development. Our expertise spans regulatory submissions support from pre-IND to marketing authorization, comprehensive safety solutions, full-service biometrics management and execution, and functional service provider (FSP) models, with a deep bench of therapeutic area expertise.

We believe in delivering strategic, in-depth insights which focus on the long-term success of our customers and their assets. This holistic approach ensures that every aspect of your drug development process is meticulously managed, from initial IND submissions through to marketing authorization approvals and post-approval activities. What sets MMS apart is our unwavering focus on data-driven methodologies and a commitment to delivering tailored, end-to-end solutions that are necessary to drive your programs and projects to success. The result is successful outcomes for our customers and the best customer satisfaction and employee stability in the industry.

Explore our solutions to see how MMS can help you achieve your drug development goals with confidence and precision.

Suggested For You

perspectives

December 11th, 2024

Why Emerging biotech companies are increasingly turning to Specialized Data CROs

regulatory intelligence

December 4th, 2024

FDA Issues Detailed Guidance on Development of Gene Therapy Products

news

December 4th, 2024

AI in Pharma and Innovative Leadership Were on Display at the Biennial MMS Scientific Symposium

perspectives

November 26th, 2024

Finding GRASEland: Navigating the New Regulatory Path for Grandfathered OTC Drugs 

perspectives

November 21st, 2024

Essential Nonclinical Strategies for Cell and Gene Therapy (CGT) Success

news

November 19th, 2024

MMS Recognized as a Top Workplace by Detroit Free Press and USA Today Network for the Fourth Consecutive Year

perspectives

November 12th, 2024

REMS Logic Modeling: Applying FDA Guidance from November 2024 CDER Webinar

news

November 8th, 2024

MMS Named a Finalist in the 2024 Fierce CRO Awards for Leadership in Regulatory Compliance

perspectives

November 6th, 2024

How to Successfully Manage Rescue Studies and Turn Around Clinical Trials Facing Failure

perspectives

October 29th, 2024

Why Outsourcing QC of Regulatory and Medical Writing Documents is a Competitive Advantage for Large Pharma Companies

perspectives

October 22nd, 2024

Choosing the Right Clinical Trial Design: A Crucial Step in Protocol Development

perspectives

October 15th, 2024

Putting the Action in Diversity Action Plans and the Real-Time Data Visualization Technology Needed to Ensure It Happens